SB3146 - 104th General Assembly (2025-2026)

340B PRICING PROGRAM REPORT
Last Action
2/10/2026 - Senate: Assigned to Executive
Statutes Amended In Order of Appearance
New Act  
Synopsis As Introduced
Creates the 340B Drug Pricing Program Reporting Act. On or before April 1, 2027 and each April 1 thereafter, requires a 340B covered entity to report the specified information and transactions to the Department of Public Health concerning the 340B covered entity's participation in or participation on behalf of the 340B covered entity in the federal 340B Program for the previous calendar year. On or before November 15, 2027 and each November 15 thereafter, requires the Department to prepare a report that aggregates the data submitted; submit the report to the General Assembly in an electronic format; and post the report on the Department's website. Provides that pharmaceutical manufacturers may request a 340B covered entity to provide specified information concerning the dispensation of 340B drugs. Sets forth provisions concerning penalties, exemptions for pharmaceutical manufacturers, and rulemaking. Provides that the Act is repealed on January 1, 2031. Effective immediately.
Actions
DateChamberAction
2/02/2026SenateFiled with Secretary by Sen. Christopher Belt
2/02/2026SenateFirst Reading
2/02/2026SenateReferred to Assignments
2/03/2026SenateChief Sponsor Changed to Sen. Adriane Johnson
2/10/2026SenateAssigned to Executive
2/19/2026SenateAdded as Chief Co-Sponsor Sen. Mattie Hunter